Philips showcases integrated radiation oncology solutions to streamline diagnosis and treatment at ASTRO 2020
October 22 2020 - 9:00AM
October 22, 2020
Radiation Oncology Orchestrator (IntelliSpace Radiation
Oncology) and Practice Management [1] can reduce the time from
patient referral to the start of treatment by up to half
Amsterdam, The Netherlands – Royal Philips (NYSE: PHG,
AEX: PHIA), a global leader in health technology, will showcase its
latest advances in radiation oncology at the American Society for
Radiation Oncology (ASTRO) annual meeting (October 24-28). During
the virtual event, Philips will showcase its comprehensive
portfolio of integrated radiation oncology systems and AI‐powered
software that helps radiation oncologists manage complexity and
boost efficiencies to accelerate the time from patient referral to
treatment.
As diagnostic and treatment workloads expand in both volume and
complexity, radiation therapy departments are under mounting
pressure to provide accurate treatment, while minimizing wait times
for patients. Today, the radiation oncology planning process can be
labor-intensive, with frequent handovers, long wait times and lags
in data transfers between systems. By optimizing workflows,
standardizing processes, and providing easy access to relevant
patient information, Philips supports care teams by integrating
clinical workflows, reducing wait times and increasing confidence
in decision-making.
“Healthcare providers are rethinking the way
they organize care in order to support a
streamlined, end-to-end exchange of data, which can help them
achieve a faster workflow, address capability gaps and reduce
costs,” said Ardie Ermers, Vice President and General Manager
Radiation Oncology at Philips. “With our broad portfolio of
oncology technologies and solutions, Philips is in a unique
position to help providers across the end-to-end patient pathway,
optimizing workflows and generating insights from integrated
diagnostics, aiming for clear care pathways and predictable
outcomes for every patient.”
An integrated solution supported by consultancy
servicesIntelliSpace Radiation Oncology [1] enables
radiotherapy departments to achieve operational excellence and
accelerate the time from referral of the patient to the start of
their treatment. By integrating the analytics and on-site change
management features of Philips’ Practice Management solution [1],
radiotherapy departments can identify and act on data-driven
insights to address performance gaps, monitor progress and drive
sustainable change.
The South West Wales Cancer Centre (SWWCC) in the UK is among
the first partner sites that have deployed the solution. “This new
intelligent patient management orchestrator helps our patients by
improving their experience by decreasing their time to treatment
and it will help us as clinicians to consistently treat every
patient to the highest quality levels,” said Dr. Russell Banner,
Clinical Oncologist, and Radiotherapy Lead at SWWCC. “Our 14-step
breast pathway had a referral-to-first treatment interval of 32
days initially. With full implementation of IntelliSpace Radiation
Oncology and the Practice Management consultants, we think it is
achievable to bring this down to just 14 days.”
Advanced Imaging and treatment planning toolsAt ASTRO and
beyond on its virtual radiation oncology experience website,
Philips will present its dedicated radiation oncology line-up,
including the Big Bore RT scanning and simulation platform (Big
Bore RT) and the comprehensive MR simulation platform (Ingenia
MR-RT).
Philips continues to advance its leading MR-only radiotherapy
portfolio, receiving 510(k) clearance from the U.S. Food and Drug
Administration (FDA) for its AI-based MRCAT Brain application
earlier this year. MRCAT reduces the organization and coordination
of scans involved in MR-CT registration, saving the patient from
undergoing another imaging procedure. MRCAT scans are now
accelerated by Compressed Sense, a technology that speeds up scans
by up to 50% [2], further helping to improve patient comfort.
Advanced imaging capabilities tailored for MR in Radiotherapy
from Philips being highlighted for ASTRO include functional imaging
using DWI XD TSE with reduced distortion [3], metal artifact
reduction with OMAR XD, and motion management with 3D Vane XD,
which supports imaging of the abdomen without the need for the
patient to hold their breath.
As the company further consolidates its radiation oncology IT
platform, Philips is also showcasing its next generation of
personalized IMRT and VMAT Therapy Planning System (Pinnacle
Evolution) which improves the quality, consistency and efficiency
of the therapy planning process.
End-to-end oncology careWith its broad portfolio of
oncology-related technologies and solutions that span the
end-to-end patient care-path, Philips is in a unique position to
help oncology care providers to connect the disparate pathway
processes and workflows to improve the efficiency, robustness and
quality of oncology care. More information on Philips’ oncology
portfolio is available here.
[1] Not available for sale in all markets.[2] Compared to
Philips scans without Compressed SENSE.[3] Compared to EPI
diffusion DWI.
For further information, please contact:
Kathy O’ReillyPhilips Global Press OfficeTel.: +1
978-221-8919E-mail: kathy.oreilly@philips.comTwitter:
@kathyoreilly
Mark GrovesPhilips Global Press OfficeTel: +31 631 639 916
Email: mark.groves@philips.com Twitter: mark_groves
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2019 sales of EUR 19.5 billion and
employs approximately 81,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- IntelliSpace Radiation Oncology
- IntelliSpace Radiation Oncology clinician discussion
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Apr 2023 to Apr 2024